top of page
tech360.tv

Chinese Supercomputer Aids in Fighting Diabetic Complications

Chinese scientists leverage Tianhe-2 supercomputer to combat diabetic complications. 2MBC, a branched-chain acylcarnitine, identified as a promising therapeutic compound. Compound enhances platelet function and accelerates blood clot formation.

China's Tianhe-2 supercomputer in Guangzhou City
Credit: CFP

Located in Guangzhou City, the Tianhe-2 is one of the fastest supercomputers in the world, ranking 16th on the TOP500 list. Using this amazing computational capability, researchers at Sun Yat-sen University discovered a promising therapeutic technique for addressing problems connected with metabolic illnesses such as diabetes.


Using the Virtual Screening on Tianhe-2 (VSTH) technology, the team discovered that 2MBC, a branched-chain acylcarnitine, can significantly accelerate blood clot development in the body. This discovery opens up new avenues for creating novel medicines and therapeutic targets for diabetic problems.


Diabetes is a common chronic disease globally, and its complications, such as blood clot development, can have serious repercussions for individuals. 2MBC improves platelet aggregate, distribution, and contractility by impacting them directly. This impact has been seen in both rodents and humans, making it a good option for future research and development.


Interestingly, gut bacteria create the chemical 2MBC. The researchers discovered that pre-treatment with antibiotics to remove gut bacteria significantly inhibits the metabolic conversion of 2MBC. This discovery emphasises the complex link between gut microbiota and metabolic diseases, providing important insights for future research.


The Tianhe-2 team is devoted to extending the drug discovery platform's capabilities. With its remarkable speed and access to massive data resources, the supercomputer has the potential to catalyse game-changing biomedical innovations.

 
  • Chinese scientists leverage Tianhe-2 supercomputer to combat diabetic complications

  • 2MBC, a branched-chain acylcarnitine, identified as a promising therapeutic compound

  • Compound enhances platelet function and accelerates blood clot formation


Source: CGTN

As technology advances and has a greater impact on our lives than ever before, being informed is the only way to keep up.  Through our product reviews and news articles, we want to be able to aid our readers in doing so. All of our reviews are carefully written, offer unique insights and critiques, and provide trustworthy recommendations. Our news stories are sourced from trustworthy sources, fact-checked by our team, and presented with the help of AI to make them easier to comprehend for our readers. If you notice any errors in our product reviews or news stories, please email us at editorial@tech360.tv.  Your input will be important in ensuring that our articles are accurate for all of our readers.

bottom of page